Published September 2018 | Version v1
Journal article

IGF-1 resist oxidative damage to HaCaT and depigmentation in mice treated with H2O2

  • 1. Department of Dermatology, The Third People's Hospital of Hangzhou, 310009, Hangzhou, Zhejiang (China)
  • 2. Department of Medicine, Baylor College of Medicine, Houston, TX, 77030 (United States)
  • 3. Department of Dermatology, Anhui Medical University Affiliated Hangzhou Clinical College, 310009, Hangzhou, Zhejiang (China)

Description

Vitiligo, an acquired pigmentary disorder of the skin, is characterized by a chronic and progressive loss of melanocyte from the epidermis and follicular reservoir. Growth factor of surrounding cells impacted on melanocytes survival. In this study, lower level of IGF-1 in the lesion was found than that in the donor area of vitiligo patients. IGF-1 improved activation of Nrf2, and inhibited ROS generation and endoplasmic reticulum dilation in HaCaT. C57BL/6 mice were treated with 5% H2O2, and combined with 50 μg/kg of IGF-1 pre-treatment or not once every day for 50 consecutive days. After 50 days, IGF-1 obviously ameliorated depigmentation of mice skin and reduced hair follicle length, skin thickness and Tyrosinase induced by H2O2. Moreover, IGF-1 significantly suppressed CD8+ T cells infiltration in mice skin, inhibited the production of IL-2 and IFN-γ, and decreased the expression of CXCL10 and CXCR3. Thus, the results indicated that IGF-1 could resist oxidative damage to HaCaT, suppress CD8+ T cells infiltration and pro-inflammatory cytokines secretion, and suppresses the thinning of epidermal layer in vivo. It suggests that IGF-1 inhibits oxidative damage to HaCaT and immunosuppressive effects on CD8+ T cells proliferation and activation to resist depigmentation induced by H2O2. This disclosed its multiple roles in the vitiligo, and shed a light on developing the application potential for IGF-1 in vitiligo.

Availability note (English)

Available from http://dx.doi.org/10.1016/j.bbrc.2018.07.004

Additional details

Identifiers

DOI
10.1016/j.bbrc.2018.07.004;
PII
S0006291X18314992;

Publishing Information

Journal Title
Biochemical and Biophysical Research Communications
Journal Volume
503
Journal Issue
4
Journal Page Range
p. 2485-2492
ISSN
0006-291X
CODEN
BBRCA9

INIS

Optional Information

Copyright
Copyright (c) 2018 Elsevier Inc. All rights reserved.